scPharmaceuticals Inc (SCPH)
4.66
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
4.65
-0.01
(-0.21%)
After-Hours: 20:00
scPharmaceuticals Shareholders Equity (Quarterly): 37.22M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 37.22M |
September 30, 2023 | 49.15M |
June 30, 2023 | 63.43M |
March 31, 2023 | 75.81M |
December 31, 2022 | 72.43M |
September 30, 2022 | 31.11M |
June 30, 2022 | 40.46M |
March 31, 2022 | 49.39M |
December 31, 2021 | 56.47M |
September 30, 2021 | 63.11M |
June 30, 2021 | 69.04M |
March 31, 2021 | 75.52M |
December 31, 2020 | 82.17M |
September 30, 2020 | 89.82M |
Date | Value |
---|---|
June 30, 2020 | 98.06M |
March 31, 2020 | 55.10M |
December 31, 2019 | 51.36M |
September 30, 2019 | 57.89M |
June 30, 2019 | 63.47M |
March 31, 2019 | 70.40M |
December 31, 2018 | 78.74M |
September 30, 2018 | 83.39M |
June 30, 2018 | 88.59M |
March 31, 2018 | 97.94M |
December 31, 2017 | 106.00M |
September 30, 2017 | 19.65M |
December 31, 2016 | -37.07M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
31.11M
Minimum
Sep 2022
98.06M
Maximum
Jun 2020
62.16M
Average
63.11M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Anika Therapeutics Inc | 212.26M |
Spero Therapeutics Inc | 106.89M |
electroCore Inc | 7.442M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 94.48M |
Total Liabilities (Quarterly) | 57.26M |
Debt to Equity Ratio | 1.043 |
Current Ratio | 7.076 |
Net Debt Paydown Yield | -0.12% |